The HIV Vaccine Trials Network (HPTN) and HIV Prevention Trials network are collaborating in doing a research/study to assess whether the anti-HIV antibody called VRC01 made from the laboratory may be able to prevent HIV infection in people who are
MASYAP part of community stakeholder process to trial new HIV prevention antibodies








